Key-figures

The Group, continuing operations2) 2016 2015 2014 2013 2012 2011
EBITDA, SEK k –278,919 95,662 1,221,925 76,389 –165,254 134,151
EBIT, SEK k –312,380 55,428 1,188,731 25,164 –201,331 112,051
Operating margin, % –335.7 11.7 67.3 5.6 –118.0 21.9
Profit margin, % –329.7 9.7 67.5 6.2 –123.5 21.9
Debt/equity ratio, multiple 0.0 0.0 0.0 0.0 0.1 0.2
Return on:
shareholders’ equity, % –18.5 1.8 84.1 3.2 –21.4 13.8
capital employed, % –19.3 2.7 80.6 3.3 –17.6 14.0
total capital, % –17.3 2.5 75.2 3.3 –16.6 12.3
Equity/assets ratio, % 90.2 89.7 90.8 85.7 81.3 80.7
Average number of shares, ‘000 26,941 29,048 31,260 31,260 31,257 29,924
Number of shares at year-end, ‘000 26,966 26,966 31,260 31,260 31,260 31,254
Earnings per share, SEK
   Basic earnings per share, continuing operations –10.94 1.09 36.24 0.51 –7.49 3.75
   Diluted earnings per share, continuing operations –10.94 1.08 35.90 0.51 –7.49 3.84
   Basic earnings per share, discontinued operations 21.44 1.49 –1.19
   Diluted earnings per share, discontinued operations 21.39 1.48 –1.19
   Basic earnings per share, all operations 10.50 2.59 36.24 –0.68 –7.49 3.75
   Diluted earnings per share, all operations 10.47 2.56 35.90 –0.68 –7.49 3.84
Equity per share, before and after dilution, SEK1) 64.38 54.04 63.42 27.27 27.99 35.05
Net worth per share, before and after dilution, SEK1) 64.38 54.04 63.42 27.27 27.99 35.05
Cash flow per share from operating activities, SEK –6.68 11.95 32.45 1.38 –4.47 1.91
Cash flow per share after investments, SEK 23.05 11.44 31.88 4.93 –4.69 –4.26
Cash flow per share after financing activities, SEK 23.03 –10.99 31.88 3.37 –7.66 –3.71
Dividend per share, SEK 0 0 0 0 0 0
Number of outstanding share warrants 62,842 238,254 294,486 249,110 394,400 712,507
Capital employed 1,733,922 1,450,109 2,032,778 955,470 963,537 1,095,576
Research and development costs/operating expenses, % 78.8 73.1 60.8 65.7 65.4 53.2

1) IAS 33 states that potential ordinary shares do not give rise to any dilution effect when their conversion to ordinary shares entails an improvement in earnings per share, which would be the case in conjunction with a conversion of the outstanding share warrants in Medivir.
2) No recalculation has occurred for 2014 and previous years with regard to the discontinued operations in 2016.

 

Six-year summary

The Group, continuing operations, SEK k 2016 2015 2014 2013 2012 2011
Income Statements1)
Net sales 93,043 474,274 1,766,989 446,146 170,647 512,626
Cost of goods sold –15,949 –38,268 –174,018 –71,771 –61,315 –70,636
Selling expenses –13,011 –48,249 –103,578 –70,486 –47,727 –84,749
Administrative expenses –70,658 –57,287 –62,518 –51,867 –59,690 –38,105
Research and development costs –307,090 –278,375 –245,754 –229,430 –203,352 –184,064
Other operating income 4,477 5,051 15,223 6,347 4,607 14,658
Other operating expenses –3,192 –1,718 –7,612 –3,775 –4,501 –34,791
Operating profit/loss –312,380 55,428 1,188,731 25,164 –201,331 114,938
Net financial items 5,655 –9,225 3,970 2,470 –9,441 25
Profit/loss after financial items –306,725 46,203 1,192,701 27,633 –210,772 114,963
Tax 11,870 –14,495 –59,966 –11,619 –23,325 4,910
Profit/loss after tax –294,855 31,708 1,132,735 16,014 –234,098 119,873

 

31 Dec 2016 31 Dec 2015 31 Dec 2014 31 Dec 2013 31 Dec 2012 31 Dec 2011
Balance Sheets
Intangible fixed assets 111,854 398,022 417,577 432,080 514,389 528,994
Tangible fixed assets 21,956 26,283 26,875 27,958 36,070 35,621
Financial fixed assets 2,500 10,001 9,659
Deferred tax receivables 1,002 43,187 49,238 78,385
Inventories and current receivables 88,209 114,008 341,317 80,025 179,771 167,833
Cash and cash equivalents 1,698,481 1,077,942 1,395,621 402,220 296,727 536,279
Equity 1,732,912 1,450,109 1,982,604 852,587 874,880 1,095,576
Deferred tax liability/provisions 351 468
Long-term interest-bearing liabilities 40,000 40,000 70,041
Long-term non-interest-bearing liabilities 448 610
Current liabilities 188,591 165,795 201,286 102,883 160,867 190,545
Balance Sheet total 1,921,503 1,616,255 2,183,891 995,470 1,076,195 1,356,772

1) No recalculation has occurred for 2014 and previous years with regard to the discontinued operations in 2016.

Page updated 4 April 2017